Published in

Lippincott, Williams & Wilkins, HemaSphere, (6), p. 30-31, 2022

DOI: 10.1097/01.hs9.0000843408.31385.3f

Links

Tools

Export citation

Search in Google Scholar

S129: Takeaim Leukemia- A Phase 1/2a Study of the Irak4 Inhibitor Emavusertib (Ca-4948) as Monotherapy or in Combination With Azacitidine or Venetoclax in Relapsed/Refractory Aml or MDS

Journal article published in 2022 by G. Garcia-Manero, R. von Roemeling, E. S. Winer, D. J. DeAngelo, S. Tarantolo, D. A. Sallman, J. Dugan, S. Groepper, A. Giagounidis, K. Götze, K. H. Metzeler, C.-C. Li, M. Lane, L. Zhou, E. Martinez and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO